232 related articles for article (PubMed ID: 26348136)
1. Selective regulation of Mmp13 by 1,25(OH)
Meyer MB; Benkusky NA; Onal M; Pike JW
J Steroid Biochem Mol Biol; 2016 Nov; 164():258-264. PubMed ID: 26348136
[TBL] [Abstract][Full Text] [Related]
2. Selective Distal Enhancer Control of the Mmp13 Gene Identified through Clustered Regularly Interspaced Short Palindromic Repeat (CRISPR) Genomic Deletions.
Meyer MB; Benkusky NA; Pike JW
J Biol Chem; 2015 Apr; 290(17):11093-107. PubMed ID: 25773540
[TBL] [Abstract][Full Text] [Related]
3. Deletion of the Distal Tnfsf11 RL-D2 Enhancer That Contributes to PTH-Mediated RANKL Expression in Osteoblast Lineage Cells Results in a High Bone Mass Phenotype in Mice.
Onal M; St John HC; Danielson AL; Pike JW
J Bone Miner Res; 2016 Feb; 31(2):416-29. PubMed ID: 26332516
[TBL] [Abstract][Full Text] [Related]
4. Genomic determinants of gene regulation by 1,25-dihydroxyvitamin D3 during osteoblast-lineage cell differentiation.
Meyer MB; Benkusky NA; Lee CH; Pike JW
J Biol Chem; 2014 Jul; 289(28):19539-54. PubMed ID: 24891508
[TBL] [Abstract][Full Text] [Related]
5. Matrix metalloproteinase 13 (MMP13) is a direct target of osteoblast-specific transcription factor osterix (Osx) in osteoblasts.
Zhang C; Tang W; Li Y
PLoS One; 2012; 7(11):e50525. PubMed ID: 23185634
[TBL] [Abstract][Full Text] [Related]
6. MEF2C Interacts With c-FOS in PTH-Stimulated Mmp13 Gene Expression in Osteoblastic Cells.
Nakatani T; Partridge NC
Endocrinology; 2017 Nov; 158(11):3778-3791. PubMed ID: 28973134
[TBL] [Abstract][Full Text] [Related]
7. Enhancers located within two introns of the vitamin D receptor gene mediate transcriptional autoregulation by 1,25-dihydroxyvitamin D3.
Zella LA; Kim S; Shevde NK; Pike JW
Mol Endocrinol; 2006 Jun; 20(6):1231-47. PubMed ID: 16497728
[TBL] [Abstract][Full Text] [Related]
8. Evidence for coordinated regulation of osteoblast function by 1,25-dihydroxyvitamin D3 and parathyroid hormone.
van Leeuwen JP; Birkenhäger JC; van den Bemd GC; Pols HA
Biochim Biophys Acta; 1996 Jun; 1312(1):54-62. PubMed ID: 8679716
[TBL] [Abstract][Full Text] [Related]
9. Multiple mechanisms are involved in inhibition of osteoblast differentiation by PTHrP and PTH in KS483 Cells.
van der Horst G; Farih-Sips H; Löwik CW; Karperien M
J Bone Miner Res; 2005 Dec; 20(12):2233-44. PubMed ID: 16294276
[TBL] [Abstract][Full Text] [Related]
10. Osteoblast-specific transcription factor Osterix increases vitamin D receptor gene expression in osteoblasts.
Zhang C; Tang W; Li Y; Yang F; Dowd DR; MacDonald PN
PLoS One; 2011; 6(10):e26504. PubMed ID: 22028889
[TBL] [Abstract][Full Text] [Related]
11. Multifunctional enhancers regulate mouse and human vitamin D receptor gene transcription.
Zella LA; Meyer MB; Nerenz RD; Lee SM; Martowicz ML; Pike JW
Mol Endocrinol; 2010 Jan; 24(1):128-47. PubMed ID: 19897601
[TBL] [Abstract][Full Text] [Related]
12. Regulation of osterix (Osx, Sp7) and the Osx promoter by parathyroid hormone in osteoblasts.
Hong SH; Lu X; Nanes MS; Mitchell J
J Mol Endocrinol; 2009 Nov; 43(5):197-207. PubMed ID: 19505977
[TBL] [Abstract][Full Text] [Related]
13. Dlx5 and mef2 regulate a novel runx2 enhancer for osteoblast-specific expression.
Kawane T; Komori H; Liu W; Moriishi T; Miyazaki T; Mori M; Matsuo Y; Takada Y; Izumi S; Jiang Q; Nishimura R; Kawai Y; Komori T
J Bone Miner Res; 2014 Sep; 29(9):1960-9. PubMed ID: 24692107
[TBL] [Abstract][Full Text] [Related]
14. Genomic mechanisms controlling renal vitamin D metabolism.
Meyer MB; Pike JW
J Steroid Biochem Mol Biol; 2023 Apr; 228():106252. PubMed ID: 36657729
[TBL] [Abstract][Full Text] [Related]
15. Regulation of the osterix (Osx, Sp7) promoter by osterix and its inhibition by parathyroid hormone.
Barbuto R; Mitchell J
J Mol Endocrinol; 2013; 51(1):99-108. PubMed ID: 23682129
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of Enhancer-mediated Hormonal Control of Vitamin D Receptor Gene Expression in Target Cells.
Lee SM; Meyer MB; Benkusky NA; O'Brien CA; Pike JW
J Biol Chem; 2015 Dec; 290(51):30573-86. PubMed ID: 26504088
[TBL] [Abstract][Full Text] [Related]
17. Sirtuin 1 is a negative regulator of parathyroid hormone stimulation of matrix metalloproteinase 13 expression in osteoblastic cells: role of sirtuin 1 in the action of PTH on osteoblasts.
Fei Y; Shimizu E; McBurney MW; Partridge NC
J Biol Chem; 2015 Mar; 290(13):8373-82. PubMed ID: 25631045
[TBL] [Abstract][Full Text] [Related]
18. 1,25-Dihydroxyvitamin D3 stimulates cyclic vitamin D receptor/retinoid X receptor DNA-binding, co-activator recruitment, and histone acetylation in intact osteoblasts.
Kim S; Shevde NK; Pike JW
J Bone Miner Res; 2005 Feb; 20(2):305-17. PubMed ID: 15647825
[TBL] [Abstract][Full Text] [Related]
19. Mannose receptor C type 2 mediates 1,25(OH)
Dong Y; Yang L; Luo W; Zhu T; Yan W; Kong J; Yuan Z; Zhao Q
Mol Cell Endocrinol; 2019 Mar; 483():74-86. PubMed ID: 30641101
[TBL] [Abstract][Full Text] [Related]
20. Nmp4/CIZ regulation of matrix metalloproteinase 13 (MMP-13) response to parathyroid hormone in osteoblasts.
Shah R; Alvarez M; Jones DR; Torrungruang K; Watt AJ; Selvamurugan N; Partridge NC; Quinn CO; Pavalko FM; Rhodes SJ; Bidwell JP
Am J Physiol Endocrinol Metab; 2004 Aug; 287(2):E289-96. PubMed ID: 15026307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
